Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos A Obejero-Paz

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Current Protocols in Pharmacology|August 26, 2014
Functional Characterization of Human Stem Cell-Derived CardiomyocytesGlenn E Kirsch, Carlos A Obejero-Paz, Andrew Bruening-Wright
The Journal of General Physiology|December 2, 2004
Y3+ block demonstrates an intracellular activation gate for the alpha1G T-type Ca2+ channelCarlos A Obejero-Paz, I Patrick Gray, Stephen W Jones
The Journal of Membrane Biology|June 1, 2010
Evaluation of a two-site, three-barrier model for permeation in Ca(V)3.1 (alpha1G) T-type calcium channels: Ca (2+), Ba (2+), Mg (2+), and Na (+)Kyle V Lopin, Carlos A Obejero-Paz, Stephen W Jones
The Journal of General Physiology|July 30, 2008
Ni2+ block of CaV3.1 (alpha1G) T-type calcium channelsCarlos A Obejero-Paz, I Patrick Gray, Stephen W Jones
The Journal of Biological Chemistry|December 14, 2001
The binding site for channel blockers that rescue misprocessed human long QT syndrome type 2 ether-a-gogo-related gene (HERG) mutationsEckhard Ficker, Carlos A Obejero-Paz, Shuxia Zhao, et al.
The Journal of General Physiology|July 30, 2008
Permeation and gating in CaV3.1 (alpha1G) T-type calcium channels effects of Ca2+, Ba2+, Mg2+, and Na+Nilofar Khan, I Patrick Gray, Carlos A Obejero-Paz, et al.
Molecular Pharmacology|September 14, 2012
Fe²⁺ block and permeation of CaV3.1 (α1G) T-type calcium channels: candidate mechanism for non-transferrin-mediated Fe²⁺ influxKyle V Lopin, I Patrick Gray, Carlos A Obejero-Paz, et al.
Scientific Reports|December 1, 2015
Quantitative Profiling of the Effects of Vanoxerine on Human Cardiac Ion Channels and its Application to Cardiac RiskCarlos A Obejero-Paz, Andrew Bruening-Wright, James Kramer, et al.
Scientific Reports|July 2, 2013
MICE models: superior to the HERG model in predicting Torsade de PointesJames Kramer, Carlos A Obejero-Paz, Glenn Myatt, et al.
The Journal of Laboratory and Clinical Medicine|December 4, 2003
Deferoxamine prevents cardiac hypertrophy and failure in the gerbil model of iron-induced cardiomyopathyTianen Yang, Gary M Brittenham, Wei-Qiang Dong, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Protocols in Pharmacology|August 26, 2014
Functional Characterization of Human Stem Cell-Derived CardiomyocytesGlenn E Kirsch, Carlos A Obejero-Paz, Andrew Bruening-Wright
The Journal of General Physiology|December 2, 2004
Y3+ block demonstrates an intracellular activation gate for the alpha1G T-type Ca2+ channelCarlos A Obejero-Paz, I Patrick Gray, Stephen W Jones
The Journal of Membrane Biology|June 1, 2010
Evaluation of a two-site, three-barrier model for permeation in Ca(V)3.1 (alpha1G) T-type calcium channels: Ca (2+), Ba (2+), Mg (2+), and Na (+)Kyle V Lopin, Carlos A Obejero-Paz, Stephen W Jones
The Journal of General Physiology|July 30, 2008
Ni2+ block of CaV3.1 (alpha1G) T-type calcium channelsCarlos A Obejero-Paz, I Patrick Gray, Stephen W Jones
The Journal of Biological Chemistry|December 14, 2001
The binding site for channel blockers that rescue misprocessed human long QT syndrome type 2 ether-a-gogo-related gene (HERG) mutationsEckhard Ficker, Carlos A Obejero-Paz, Shuxia Zhao, et al.
The Journal of General Physiology|July 30, 2008
Permeation and gating in CaV3.1 (alpha1G) T-type calcium channels effects of Ca2+, Ba2+, Mg2+, and Na+Nilofar Khan, I Patrick Gray, Carlos A Obejero-Paz, et al.
Molecular Pharmacology|September 14, 2012
Fe²⁺ block and permeation of CaV3.1 (α1G) T-type calcium channels: candidate mechanism for non-transferrin-mediated Fe²⁺ influxKyle V Lopin, I Patrick Gray, Carlos A Obejero-Paz, et al.
Scientific Reports|December 1, 2015
Quantitative Profiling of the Effects of Vanoxerine on Human Cardiac Ion Channels and its Application to Cardiac RiskCarlos A Obejero-Paz, Andrew Bruening-Wright, James Kramer, et al.
Scientific Reports|July 2, 2013
MICE models: superior to the HERG model in predicting Torsade de PointesJames Kramer, Carlos A Obejero-Paz, Glenn Myatt, et al.
The Journal of Laboratory and Clinical Medicine|December 4, 2003
Deferoxamine prevents cardiac hypertrophy and failure in the gerbil model of iron-induced cardiomyopathyTianen Yang, Gary M Brittenham, Wei-Qiang Dong, et al.
Pageof 2